Former Bristol Execs Schiff And Lane Indicted On Securities Fraud Charges
This article was originally published in The Pink Sheet Daily
Executive Summary
Former Bristol-Myers Squibb CFO Fred Schiff and former Worldwide Medicines Group President Richard Lane face charges of securities fraud and conspiracy to commit securities fraud in connection with the Department of Justice investigation of Bristol's "channel stuffing" practices
You may also be interested in...
Sanctura Co-Promotion Deal
Esprit Pharma has become Indevus' new co-promotion partner for Sanctura (trospium), after acquiring marketing rights for the overactive bladder agent from Pliva
Sanctura Co-Promotion Deal
Esprit Pharma has become Indevus' new co-promotion partner for Sanctura (trospium), after acquiring marketing rights for the overactive bladder agent from Pliva
Bristol Settles DoJ "Channel Stuffing" Investigation For $300 Mil.
The company will take a $249 mil. charge in the second quarter, in addition to a first quarter charge of $51 mil. The monies will be added to a shareholder fund created under a separate, earlier settlement with SEC. CEO Dolan loses his chairman's title under the pact, and Bristol agrees to cooperate with investigations of former executives.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: